Evidence map›Paper›PMID 39392634›Full record

ArticleJAMA network open2024

Recombinant Zoster Vaccination Among US Veterans Receiving Immunosuppressive Medications.

Sharon Abada, Jing Li, Gary Tarasovsky, Cherish Wilson, Jinoos Yazdany, Mary A Whooley, Gabriela Schmajuk

Abstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sharon AbadaUniversity of California San Francisco.
Jing LiUniversity of California San Francisco.
Gary TarasovskyUniversity of California San Francisco.
Cherish WilsonUniversity of California San Francisco.
Jinoos YazdanyUniversity of California San Francisco.
Mary A WhooleyUniversity of California San Francisco.
Gabriela SchmajukUniversity of California San Francisco.

Funding

Advancing Quality and Outcomes Measurement in RheumatologyK24AR074534 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Jinoos Yazdany · 2019 to 2026
$1.5M
AHRQ HHS R01 HS028024NIAMS NIH HHS K24 AR074534
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Herpes ZosterHerpes Zoster VaccineImmunosuppressive AgentsVeteransAgedFemaleHumansMaleMiddle AgedUnited StatesVaccinationVaccines, SyntheticHerpes Zoster VaccineImmunosuppressive AgentsVaccines, Synthetic

Identifiers

PMID39392634
PMCPMC11581597

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.